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Background: Wound healing is a natural process that enables tissue repair after an injury. To shorten its duration
and minimize associated complications, wounds are treated with medications. Currently there is a growing interest
in the use of alternative wound dressing agents such as plant extracts. One plant used traditionally in wound
treatment is Pupalia lappacea. In view of its use in wound care, we investigated the wound healing activities of 80%
methanolic leave extract of Pupalia lappacea using excision, incision and dead space wound models. Also its effects
on three common wound contaminants were investigated.
Methods: Excision wounds were created, contaminated with microbes and treated with ointments (10% and 20%
w/w) prepared from Pupalia lappacea. Incision and dead space wounds were also created in rats which were
subsequently dosed orally with the extract. The wound healing activities of Pupalia lappacea ointment on excision
wound was assessed by rates of wound contraction and epithelialization as well as its antibacterial effects. The
effects of Pupalia lappacea on incision and dead-space wounds were determined by the wound breaking strengths
and weights of the granuloma tissues formed, respectively.
Results: Pupalia. lappacea ointments significantly (p < 0.05) accelerated wound healing with 20% ointment having
the highest percentage wound contraction and rate of epithelialization. At 4, 7 and 14 days post treatment, mean
total viable bacterial count of excision wounds of the extract treated groups were significantly (p < 0.05) lower
compared against the control. Wound breaking strengths and weights of granuloma tissues formed in the extract
treated groups were significantly (p < 0.05) higher than those of the control group. The minimum inhibitory
concentration values obtained for the Pupalia lappacea extract against Pseudomonas aeruginosa, Staphylococcus
aureus and Bacillus subtilis were 9 mg/ml, 4 mg/ml and 3 mg/ml, respectively, while the corresponding minimum
bactericidal concentrations were 10 mg/ml, 8 mg/ml and 7 mg/ml.
Conclusion: The results obtained showed that Pupalia. lappacea has good wound healing and antibacterial
activities. These findings validate the use of this plant in traditional medicine for treatment of wounds.
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A wound refers to an injury to the skin or underlying tis-
sues or organs [1]. Dermal wounds are often caused by sur-
gery, trauma, and chemicals or as a result of diseases [1,2].
Intentionally created dermal wounds can be incisional,
whereby the wound is brought about by surgical cutting
into the skin with a scalpel or excision wound created* Correspondence: onlymadu2010@yahoo.com
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article, unless otherwise stated.when a part of the skin is cut off [3]. The process of tissue
repair after an insult to the tissue (wound) is called ‘wound
healing’ [4]. Wound healing is an intricate process in which
usually the skin repairs itself [5]. The process involves four
overlapping phases: haemostasis (ceasation of bleeding), in-
flammation, proliferation, and remodeling [4,5].
In haemostasis, thromboxane synthase (TXS) converts
prostaglandin H2 into thromboxane A2 which causes
vasoconstriction and platelet aggregation [6]. Failure of
the haemostatic process is prevented by plasminogen acti-
vator inhibitor type 1 (PAI-1), an inhibitor of fibrinolysisentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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icals to kill wound contaminating bacteria [8,9]. Heme and
heme proteins which accumulate at the local site of the
wound have prooxidative and proinflammatory properties
by inducing the expression of adhesion molecules, causing
vascular permeability and leukocyte infiltration. These ac-
tions initiate wound healing process [5]. Conversely, heme
oxygenase-1 (HO-1) has anti-inflammatory and antioxi-
dant activities and is responsible for a wide range of wound
healing functions. It converts heme into biliverdin/bilirubin,
iron and carbon monoxide, which are potent antioxidant
products [5]. In proliferation phase, overexpression of
HO-1 helps to accelerate wound healing such as amelior-
ation of inflammation, proliferation and protection against
endothelial cell apoptosis [10]. In remodeling phase, matrix
metalloproteinases (MMPs) plays a major role in wound
healing by extracellular matrix (ECM) remodeling [11].
The length of time it takes for wound healing process to
be complete is dependent on the rate of availability of bio-
chemical substances required for each phase to occur. To
shorten the duration of the healing process and minimize
complications (such as overwhelming bacterial wound con-
tamination) of natural healing, medical professionals use
orthodox medications (which increase the rate of healing
process and/or control secondary microbial wound con-
tamination) to treat wounds [12]. But, the prices of these
orthodox medications are exorbitant and many wound con-
taminating bacteria are becoming increasingly resistant to
their effects [13].
In traditional medicine, medicinal plants are used in
the preparation of decoctions which are applied to der-
mal wounds to enable healing [14]. The efficacies of
these plants in wound healing have been experienced
and passed on from one generation to the other. One
of these medicinal plants widely used traditionally in
Nsukka Southeast, Nigeria in treating wounds is Pupalia
lappacea (Family Amaranthaceae). The common name is
forest Burr or creeping cork’s comb. It is an erect or strag-
gling under shrub with flowers in spicate clusters, and it
usually grows along hedges [13]. It is used in agrihorticul-
ture as a fodder [15]. Traditional practitioners including
those in Nsukka, claim that foliage parts of P. lappacea
are used in form of poultices and decoctions to treat dif-
ferent ailments such as bone fractures and inflammatory
conditions, boils, cough, fever, leprosy sores, flatulence,
jaundice, abdominal colic, cephalgia, diarrhoea, paraly-
sis, erectile dysfunction, vomiting, toothache, cuts, chronic
wounds, fever and malaria [13,16-20]. For the treatment of
wounds, the leaf paste and the fruit juice is applied exter-
nally [13]. Scientific investigations have validated some of
these claims such as antimalaria [20], anticancer [13], anti-
nociceptive and antipyretic [18] activities of the P. lappacea
extract. No study has been done to evaluate its wound
healing and antibacterial activities.Moreover, chemical investigations of P. lappacea leaf
extract revealed that it consists of 8 compounds which
included: 1-docosanol, stearic acid, stigmasterol, sitosterol,
N-benzoyl-L-phenyl alaninol acetate, setosterol-3-O-D-
glucopyranoside, stigmasterol-3-O-D-glucopyranoside and
20-hydroxyl ecdysone [21]. These biochemical compounds
have been shown to promote wound healing process in
animals and humans. Stigmaesterol have been shown to
exhibit haemostatic [22] and anti-inflammatory activities
[5,23]. The 20-hydroxyl ecdysyne promoted protein syn-
thesis and wound healing in animals and humans [24].
Docosanol was used by to treat herpes simplex virus cuta-
neous wounds in mice [25]. Plant extract that contains
N-benzoyl-L-phenyl alaninol exhibited antibacterial ac-
tivity [26]. Since some of the compounds contained in
P. lappacea leaf extract showed activities involved in
wound healing process, the plant extract may exhibit
wound healing activities in animals and humans as
claimed by the traditional practitioners. The objective of
this study was therefore to evaluate the wound healing
and antibacterial activities of P. lappacea methanolic
leaf extract in rats.
Methods
The experimental protocols used in this study was ap-
proved by the Ethics Committee of the University of
Nigeria, Nsukka and conforms with the guide to the care
and use of animals in research and teaching of University
of Nigeria, Nsukka, Enugu State Nigeria.
Animals
A total of 92 8-week-old male albino Wistar rats weighing
between 129 and 131 g were obtained from the laboratory
animal unit, Faculty of Veterinary Medicine, University of
Nigeria, Nsukka. They were fed on commercial growers
mash (Top feeds®) and water was provided ad libitum.
These rats were acclimatized for 2 weeks in the animal
house at the Department of Veterinary Surgery, University
of Nigeria, Nsukka.
Plant collection and identification
Fresh leaves of Pupalia lappacea were collected from
Obollo-Afor in Nsukka Local Government Area Enugu
State, Nigeria, in the month of March 2013 and were
identified at the International Center for Ethnomedicine
and Drug Development (InterCEDD), Nsukka, by a plant
taxonomist, Mr. A. Ozioko. Samples were registered and
deposited in the center’s herbarium.
Extraction
Half a kilogram of the leaves were air dried at room
temperature for 2 weeks and then pulverized using the
laboratory grinding machine at the Department of Crop
Science, University of Nigeria, Nsukka. The pulverized
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intermittent vigorous shaking at every 2 hr. After 48 hr,
the mixture was filtered and the extract concentrated
using a rotary evaporator set at 40°C. The dried extract
was weighed and the percentage yield calculated. The ex-
tract was then stored at 4°C in a refrigerator before use.
Acute toxicity test
Thirty adult rats were randomly divided into six groups
of five animals per group. The animals were deprived
water for 16 hr before administration of the extract. The
increasing doses of the extract 200, 400, 600, 1000 and
2000 mg/kg body weight suspended in dimethylsulfoxide
(DMSO) was administered orally to the test groups, re-
spectively, using a ball-tipped intubation needle fitted onto
a syringe. The last group received 1 ml/kg of DMSO and
served as the control. The rats were allowed access to food
and water ad libitum and were observed for 48 hr for be-
havioural changes and death. The time of onset, intensity,
and duration of these symptoms, if any, was recorded.
Phytochemical analysis for bioactive substances
The methanolic leaf extract was screened for the pres-
ence of bioactive components following the methods of
Trease and Evans [27].
Preparation of ointments
The method of Okore et al. [28] was adopted in prepar-
ation of two herbal ointments containing 10% w/w and
20% w/w of the extract in sterile soft white paraffin. Im-
mediately after preparation, the ointments were aseptic-
ally transferred into sterile cream tubes and sealed.
Pathogens and preparation of inocula
The bacterial organisms - Pseudomonas aeruginosa, Sta-
pylococcus aureus and Bacillus subtilis used in this study
were collected from the Department of Pharmaceutics,
University of Nigeria, Nsukka. They were clinical wound
isolates from patients in Nsukka, Nigeria, fully identified
and maintained on nutrient agar slope at 4°C at the
Department of Pharmaceutical Microbiology Laboratory,
University of Nigeria, Nsukka. Prior to use, the organisms
were sub-cultured on sterile nutrient agar plate, incubated
aerobically at 37°C for 24 hr. Colonies of each organism
was homogenized in sterile phosphate buffered saline (PBS)
and the turbidity adjusted to correspond to 0.5 McFarland’s
turbidity standard (equivalent to 1 × 108 cfu/ml). The stan-
dardized broth cultures were kept at 4°C until needed.
Determination of minimum inhibitory concentration (MIC)
and minimum bactericidal concentration (MBC)
MIC of the extract was determined by macro broth dilu-
tion following the method described by Baron and Fine-
gold [29]. Dilution of P. lappacea extract was made tovarious concentrations of 1, 2, 3, 4, 5, 6, 7, 8, 9 and
10 mg/ml in series of test tubes. Equal volume of the ex-
tract and sterile nutrient broth were mixed. Specifically,
0.1 ml of standardized inoculum (1 × 108 cfu/ml) of each
of the test organism was added to each tube. The tubes
were incubated aerobically at 37°C for 24 h. Two control
tubes were maintained for each test batch. These included
antibiotic control (tube containing extract and the growth
medium without inoculum) and organism control (the
tube containing the growth medium, physiological saline
and the inoculum). The lowest concentration (highest di-
lution) of the extract that produced no visible bacterial
growth (no turbidity) when compared with the control
tubes were regarded as MIC. However, the MBC was de-
termined by sub-culturing the test dilution on to a fresh
drug-free nutrient agar and incubated further for 24 hr.
The highest dilution that yielded no single bacterial col-
ony on a solid medium was taken as MBC.Wound healing studies
Creation and contamination of excision wound
Thirty two rats were anaesthesized with 10 mg/kg body
weight of xylazine hydrochloride and 50 mg/kg ketamine
hydrochloride. Their dorsum was shaved and disinfected
with methylated spirit. Then, full thickness excision wounds
were created following the method described by Morton
and Malone [30].
Post wounding, the rats were randomly assigned into
4 groups of 8 animals per group. Then, using sterile
Pasteur pipettes, wound on each animal was contaminated
by flooding with 1 ml of standardized broth culture of each
test organism. To minimize further microbial contamin-
ation of wound, each animal was carefully placed individu-
ally in disinfected cages kept in a disinfected, clean and
dust-free animal house in the Department of Veterinary
Surgery, University of Nigeria, Nsukka. The wounds were
not treated for 24 hr post contamination to ensure coloni-
zation and establishment of infection. Treatment of animal
wound commenced 48 hr post contamination. Four treat-
ment groups consisting of 5 animals per group were treated
as follows: groups I and II were treated topically with 20%
and 10% P. lappacea leaf extract ointment (PLLEO), re-
spectively, while groups III and IV were treated with genta-
micin sulphate and sterile soft white paraffin, respectively.
Treatment of the animals continued until complete healing
occurred.Percentage wound contraction
The wound diameter of each animal was measured at
7, 10, 13, 16, 19, 21, 24 and 27 days post wounding
(dpw) using a transparent meter rule, and the percent-
age wound contraction calculated using the method of
Ezike et al. [31].









Keys: +++ = appreciable amount, ++ =moderate amount, + = trace amount,
− = completely absent.
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Period of wound epithelialization was calculated as the
number of days required for the scar to fall off leaving
no raw wound [32]. The mean days for wound epitheli-
alization for each group were calculated.
Determination of wound microbial load
At 4, 7 and 14 days post-treatment (dpt), wound swabs
from each animal was taken in duplicate using sterile swab
sticks. The total viable count of the wound was deter-
mined following the standard plate counting method [33].
Briefly, each swab was inoculated into sterile nutrient
broth to make stock solutions which was used for double-
fold (10−2) dilutions. Using a sterile pipette, 0.1 ml of the
10−2 dilution was introduced on the surface of sterile
nutrient agar and a sterile glass spreader was used for
even distribution of the inoculum. The inoculated plates
were incubated at 37°C for 24 hours and the colonies
were counted using a colony counter.
Incision wound
The method of Rathi et al. [34] was adopted. Fifteen rats
were anaesthetized with 10 mg/kg body weight of xylazine
hydrochloride and 50 mg/kg ketamine hydrochloride. Their
dorsum was prepared for aseptic surgery. Then, paraverteb-
ral (5 cm) full thickness skin incisions were made on the
animals using sterile scalpel blade. The incisions were
sutured using size 2/0 silk thread with sterile swaged-on
traumatic needle. Three treatment groups consisting of
5 animals per group were treated as follows: groups A
and B were dosed orally with 300 mg/kg of 20% and
10% of the extract, respectively, while group C was given
1 ml/kg of sterile normal saline. The animals were treated
daily for a period of 7 days. Sutures were removed at 8
dpw, and the wound breaking strength determined at 10
dpw using the constant water flow technique [35].
Dead space wound
Dead space wound were created following the method
described by Rathi et al. [34]. Fifteen rats were randomly
assigned into 3 groups of 5 animals per group. Under
general anaesthesia (achieved using 10 mg/kg body weight
of xylazine hydrochloride and 50 mg/kg ketamine hydro-
chloride), subcutaneous dead space wound were created in
the region of the axilla by making a pouch through a small
nip in the skin. Granuloma formation was induced by
implanting sterile cotton pellets (30 mg) one on each axil-
lae. The wounds were sutured and mopped with alcoholic
swab. The animals were placed individually in a metal cage
after grouping them to avoid them biting each other’s
wound. Groups D and E were administered orally with
300 mg/kg of 20% and 10% of the extract, respectively,
while group F was given 1 ml/kg of sterile normal saline,
for 8 days. At day 10, rats were euthanatized and thecotton pellets together with the granuloma tissues were
carefully removed, dried in the oven at 60°C, weighed and
compared with the control.
Statistical analysis
The data obtained were analysed using one way analysis




The methanolic leaf extract of P. lappacea had an aro-
matic smell and was greenish-black in colour. The per-
centage yield was 13.5% w/w material.
Acute toxicity test
Administration of methanolic leaf extract of P. lappacea
suspended in DMSO to rats even at the highest dose of
2000 mg/kg did not produce any death in the treated
groups. No sign of acute toxicity was also observed.
Phytochemical analysis
Preliminary phytochemical analysis qualitatively revealed
the presence of steroids, glycosides, saponins, flavonoids,
alkaloids, sugar and phenol. These were ascertained from
the reactions involving colour changes, haemolysis, tur-
bidity, layers, emulsification and precipitation (Table 1).
Minimum inhibitory and bactericidal concentrations of
P. lappacea extract on wound isolates
The MIC values obtained for the P. lappacea extract
against P. aeruginosa, S. aureus and B. subtilis was 9 mg/
ml, 4 mg/ml and 3 mg/ml, respectively, while the corre-
sponding MBC were 10 mg/ml, 8 mg/ml and 7 mg/ml, re-
spectively (Table 2).
Wound contraction
The percentage wound contraction in group I (20% ex-
tract treated) at 7 dpw was significantly (p < 0.05) high
compared to groups II (10% extract treated), III (genta-
micin treated) and IV (soft white paraffin treated). At 16,
Table 2 Minimum inhibitory and bactericidal concentrations
of P. lappacea extract on tested bacterial organisms
Bacterial organism MIC (mg/ml) MBC (mg/ml)
Pseudomonas aeruginosa 9 10
Staphylococcus aureus 4 8
Bacillus subtilis 3 7
Key: mg/ml, milligram per millilitre.
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tion in group I was the highest, it was not statistically
significant (p > 0.05) compared to that of group III, but
the percentage wound contraction of animals in groups I
and III were significantly (p < 0.05) higher than those in
groups II and IV. Animals in group IV showed signifi-
cantly (p < 0.05) the least contraction rate throughout the
study period. For all groups, most wound contraction oc-
curred between 7 and 21 dpw (Table 3).
Wound epithelialization
Epithelialization occurred between 18 and 25 dpw (Table 4).
Epithelialization was significantly (p < 0.05) faster in animals
in group I compared with those in groups II and IV. There
was no significant difference (p > 0.05) in epithelialization
time of wound between animals in groups I and III.
Wound bacterial load
At 4 dpt, mean total viable count obtained in the treated
groups (I, II and III) were significantly (p < 0.05) lower
compared against the untreated control. Similar trend
was observed at 7 and 14 dpt (Table 5).
Incision wound
The wound breaking strength results showed a signifi-
cant (p < 0.05) increase in the healed wounded tissue in
groups A and B (extract treated) when compared against
the control (Table 6).
Dead space wound
The result of the effect of the methanolic leaf extract of
P. lappacea on granuloma weight showed that the weight
of granuloma tissue of animals in group D (300 mg/kg ofTable 3 Percentage wound contraction in rats post infliction
Group (Treatment) Mean ± standard error of
7 10 13 16
I (20% PLLEO) 18.0 ± 3.5a 35.6 ± 5.3 35.7 ± 6. 8 39
II (10% PLLEO) 8.1 ± 1.2b 39.8 ± 2.2 22.6 ± 2.8 22
III (Gentamicin ointment) 7.9 ± 1.5bc 36.7 ± 6.8 26.8 ± 5.4 36
IV (Normal saline) 8.7 ± 3.0bd 25.4 ± 4.6 23.3 ± 5.4 21
Key: PLLEO = Pupalia lappacea leaf extract ointment.
Different superscripts a,b,c,d across a column indicate significant difference in means20% extract treated) was significantly (p < 0.05) higher than
those in groups E and F (control) (Table 7).
Discussion
Wound healing according to Al-Henhena et al. [36] is a
complex and dynamic process by which cellular struc-
tures and tissue layers in a damaged tissue restores itself
as closely as possible to its original state. Wound con-
traction begins a week post wounding at the fibroblastic
stage with the wound area undergoing shrinkage [36,37].
In the present study, topical application of P. lappaceae
extract significantly accelerated wound healing with 20%
ointment having the highest percentage wound contrac-
tion ability followed by gentamicin (a commercially sold
antimicrobial agent used in dressing wounds) and 10%
ointment of P. lapeacae. Wound contraction is made
possible either due to an enhanced activity of fibroblast in
regenerated wound tissue [38]. Myofibroblasts are believed
to play a key role in wound contraction by exerting tension
on surrounding extracellular matrix and secreting collagen
which stabilizes the contraction [39]. The contracture po-
tency of wounds might also be due to the ability of the
wound dressing agents to enhance the synthesis in addition
to collagen, fibronectin transforming growth factor BI [40].
There is also a report on increase levels of hexosamine and
uric acid (matrix molecules) during early stage of wound
healing [41]. In view of the above reports, the wound con-
traction and healing effects of P. lappacea might be attrib-
uted to its ability to stimulate and increase the synthesis of
one or more of the above mentioned cells and substances/
factors known to promote wound healing.
Stimulation of epithelial cell proliferations and angio-
genesis are vital for wound healing process to take place
[42]. Wound epithelialization is a process whereby there
is epithelial regeneration post wounding with the epithe-
lial cells proliferating and migrating over the wound bed,
thereby providing a protective cover for the freshly formed
tissues [43]. P. lapaceae extract might have accelerated
epithelial regeneration due to its ability to promote angio-
genesis and collagen formation and depositions [44,45].
According to Cohen et al. [46], collagen is a principal
component of connective tissue and provides a structural
framework for the regenerating tissue. Angiogenesis inof excision wounds
mean wound contraction at days post wounding
19 21 24 27
.9 ± 0.7a 70.2 ± 13.4a 79.9 ± 13.4a 100 ± 0.0a 100.0 ± 0.0a
.9 ± 4.3b 35.7 ± 5.8b 44.2 ± 7.4b 89.0 ± 1.0a 100.0 ± 0.0a
.7 ± 8.0a 63.3 ± 15.4a 70.9 ± 13.0a 100.0 ± 0.0a 100.0 ± 0.0a
.0 ± 4.9c 22.4 ± 5.7c 47.8 ± 14.8b 65.1 ± 10.4b 87.0 ± 8.3b
at p < 0.05.
Table 4 Epithelialization time of rats post infliction of
excision wound
Group (Treatment) Mean ± standard error of mean
epithelialization time (days)
I (20% PLLEO) 18.6 ± 0.5a
II (10% PLLEO) 22.0 ± 0.1b
III (Gentamicin ointment) 19.6 ± 0.3a
IV (Normal saline) 25.2 ± 0.2b
Key: PLLEO = Pupalia lappacea leaf extract ointment.
Different superscripts a,b across a column indicate significant difference in
means at p < 0.05.
Table 6 Wound breaking strength post infliction of
incision wound
Group (Treatment) Mean ± standard error of mean
wound breaking strength
A (300 mg/kg of 20% PLLE) 813.8 ± 57.2a
B (300 mg/kg of 10% PLLE) 754.3 ± 62.5a
C (Control) 478.8 ± 19.1b
Key: PPLE = P. lapaccea leaf extract.
Different superscripts a,b across a column indicate significant difference in
means at p < 0.05.
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lation to the wound site thereby providing oxygen and
nutrients necessary for healing process that include re-
epithelialization [47].
Wound tensile strength which is one of the indices for
assessing wound healing is determined by the amount of
fibroblast proliferation, collagen synthesis and neovascu-
larization [38]. In this study, two models viz incisional
and dead space wound were used to assess the effect
of the methanolic leaf extract of Pupalia lappaceae on
the tensile strength of the healed tissues. According to
Kumar et al. [48], collagen which principally strengthens
the wound and support extracellular tissue is composed
of amino acids. Nayak et al. [32] also documented that
the increase in the granuloma weight is associated with
the presence of high content of protein. The pro-healing
property of the extract by these facts might be attributed
to its ability to promote protein synthesis leading to in-
crease in the tensile strength. This ability to promote pro-
tein synthesis was dose dependent since the group that
received 20% extract did better than the group that was
given 10% of the extract. Although the mechanism of the
increase in the tensile strength was not investigated in this
study, the increased tensile strength could further be at-
tributed to the ability of the extract to increase the Van
der waals force interaction among the hydrogen ion bonds
of the tripled helix collagen, leading to twisting of the col-
lagen fibers [47]. The more the twisting of these collagenTable 5 Total viable bacterial cell population from
excision wounds of rats
Group (Treatment) Mean ± standard error of mean total
viable count at days post-treatment
4 7 14
I (20% PLLEO) 5.00 ± 79a 4.50 ± 87a 0.30 ± 20a
II (10% PLLEO) 6.00 ± 1.40a 3.80 ± 0.41a 0.70 ± 0.25a
III (Gentamicin ointment) 6.30 ± 1.46a 4.20 ± 2.28a 0.80 ± 0.44a
IV (Normal saline) 17.90 ± 2.76b 6.10 ± 1.62b 1.40 ± 0.33b
Key: PLLEO = Pupalia lappacea leaf extract ointment.
Different superscript a,b across a column indicate significant difference in
means at p < 0.05.fibers, the greater the tensile strength and invariably the
better healing of wounds [47].
The significant decreases in wound bacterial load in
the treated groups suggest that the extract has in vivo
antibacterial effect against the tested microorganisms which
are involved in wound contamination. The extract was able
to reduce wound bacterial load comparable to the reference
drug, gentamicin. The antibacterial activity of the extract
is further supported by the MIC result which showed that
P. lappacea leaf methanolic extract exhibited bacterio-
static activity against the organisms at the concentrations
shown in Table 2. The corresponding MBCs of 10 mg,
8 mg/ml and 7 mg/ml, respectively, further suggest that
the extract was bacteriostatic at lower concentrations but
bactericidal at higher concentrations.
The understanding and control of microbial infection
of wounds is very important for better healing and its
management [49]. Post operative wounds are usually in-
fected by bacterial organisms [50]. Signs of bacterial in-
fection of wounds are restlessness and scratching/biting
of wound site [36]. Other signs include delay in the onset of
the proliferative and remodeling phases of wound healing
process due to the release of free radical and lytic enzymes
at the wound site [51]. The delay in the wound healing by
these free radicals is achieved by the ability of the free rad-
ical to destroy the lipids, proteins and extracellular matrix
[52]. The absence of irritation and/or pain at wound site
during treatment and the significant increase in the rate of
wound contraction and wound re-epithelialization is a re-
flection of good antibacterial potentials of the plant as con-
tained in the in vivo and in vitro antibacterial assay results.
The antibacterial activity exhibited by the P. lappacea leafTable 7 Mean granuloma weight post infliction of dead
space wounds
Group (Treatment) Mean ± standard error of
mean granuloma weight
D (300 mg/kg of 20% PLLE) 74.0 ± 4.3b
E (300 mg/kg of 10% PLLE) 70.8 ± 1.8a
F (Control) 70.8 ± 1.8a
Key: PLLE = P. lapaccea leaf extract.
Different superscript a,b across a column indicate significant difference in
means at p < 0.05.
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and pytochemical constituents [53]. In this study, phyto-
chemical analysis showed that P. lappacea methanolic leaf
extract contained flavonoids, and flavonoids isolated from
medicinal plants have been shown to possess antimicrobial
activities [54]. Antioxidants have been reported to play a
significant role in wound healing process by protecting tis-
sues from oxidative damage [55]. It has been documented
that plants with antibacterial and antioxidant properties en-
hance wound healing by accelerating wound contraction
and re-epithelialization [31,52,56].
Conclusion
The methanolic leaf extract of Pupalia lappacea showed
remarkable dose dependent effect on wound contraction,
wound epithelialization and wound tensile strength. The
antibacterial studies showed that the plant exhibited good
in vivo and in vitro antibacterial effects. These results valid-
ate the use of this plant in folkloric medicine for the treat-
ment of wounds.
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